Global X Funds Global X Aging Population ETF(AGNG · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$34.53
- 52-Week Range
- $31.14 – $39.48
- YTD
- -4.22%
- IV Rank (30D)
- 83.16
- Straddle Price
- $2.02
- P/C Vol Ratio
- 0.18
Info
Global X Funds Global X Aging Population ETF (AGNG) ETF
- Exchange
- XNAS
- Inception
- 2016-05-09
- Has Options
- Yes
ETF Profile
holdings as of 2026-06-08
Holdings
90
AUM
$80.5M
Provider
Globalx
Inception
2016-05-09
Exchange
XNAS
Data As Of
2026-06-08
Expense Ratio
—
Dividend Yield
0.90%
Distribution
Semi-Annual
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2025-12-30 | 2026-01-07 | $0.1722 | CD |
| 2025-06-27 | 2025-07-07 | $0.1422 | CD |
| 2024-12-30 | 2025-01-07 | $0.1462 | CD |
| 2024-06-27 | 2024-07-05 | $0.1043 | CD |
| 2023-12-28 | 2024-01-08 | $0.1213 | CD |
| 2023-06-29 | 2023-07-10 | $0.1516 | CD |
Asset Allocation
Top Holdings
top 50 of 90 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| LLY | ELI LILLY & CO | 3.78% | Equity (US) | — |
| — | NOVO NORDISK A/S-B | 3.54% | Cash/Money Market | — |
| EW | EDWARDS LIFESCIENCES CORP | 3.40% | Equity (US) | — |
| ABBV | ABBVIE INC | 3.29% | Equity (US) | — |
| — | ROCHE HOLDING AG-BR | 3.12% | Cash/Money Market | — |
| MRK | MERCK & CO. INC. | 3.06% | Equity (US) | — |
| AMGN | AMGEN INC | 3.06% | Equity (US) | — |
| WELL | WELLTOWER INC | 3.03% | Equity (US) | — |
| JNJ | JOHNSON & JOHNSON | 3.01% | Equity (US) | — |
| — | UCB SA | 2.98% | Cash/Money Market | — |
| BMY | BRISTOL-MYERS SQUIBB CO | 2.94% | Equity (US) | — |
| VTR | VENTAS INC | 2.93% | Equity (US) | — |
| MDT | MEDTRONIC PLC | 2.89% | Equity (US) | — |
| SYK | STRYKER CORP | 2.80% | Equity (US) | — |
| AZN | ASTRAZENECA PLC | 2.78% | Equity (US) | — |
| — | CHUGAI PHARMACEUTICAL CO LTD | 2.66% | Equity (US) | — |
| — | SANDOZ GROUP AG | 2.58% | Cash/Money Market | — |
| REGN | REGENERON PHARMACEUTICALS | 2.50% | Equity (US) | — |
| BSX | BOSTON SCIENTIFIC CORP | 2.50% | Equity (US) | — |
| — | ALCON INC | 2.39% | Cash/Money Market | — |
| ONC | BEONE MEDICINES LTD-ADR | 2.14% | Equity (US) | — |
| DXCM | DEXCOM INC | 2.12% | Equity (US) | — |
| — | CELLTRION INC | 1.81% | Cash/Money Market | — |
| — | ASTELLAS PHARMA INC | 1.74% | Cash/Money Market | — |
| UTHR | UNITED THERAPEUTICS CORP | 1.72% | Equity (US) | — |
| — | HANSOH PHARMACEUTICAL GROUP | 1.59% | Equity (US) | — |
| — | TERUMO CORP | 1.52% | Cash/Money Market | — |
| INCY | INCYTE CORP | 1.44% | Equity (US) | — |
| — | STRAUMANN HOLDING AG-REG | 1.37% | Equity (US) | — |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1.22% | Equity (US) | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.17% | Equity (US) | — |
| — | GENMAB A/S | 1.15% | Cash/Money Market | — |
| — | SONOVA HOLDING AG-REG | 1.11% | Equity (US) | — |
| EXEL | EXELIXIS INC | 0.96% | Equity (US) | — |
| — | SMITH & NEPHEW PLC | 0.93% | Cash/Money Market | — |
| OHI | OMEGA HEALTHCARE INVESTORS | 0.93% | Equity (US) | — |
| — | FRESENIUS MEDICAL CARE AG | 0.92% | Equity (US) | — |
| DVA | DAVITA INC | 0.92% | Equity (US) | — |
| PODD | INSULET CORP | 0.77% | Equity (US) | — |
| ENSG | ENSIGN GROUP INC/THE | 0.65% | Equity (US) | — |
| HALO | HALOZYME THERAPEUTICS INC | 0.60% | Equity (US) | — |
| — | DEMANT A/S | 0.60% | Cash/Money Market | — |
| GKOS | GLAUKOS CORP | 0.51% | Equity (US) | — |
| NVCR | NOVOCURE LTD | 0.48% | Equity (US) | — |
| — | AEDIFICA | 0.47% | Cash/Money Market | — |
| — | YPSOMED HOLDING AG-REG | 0.43% | Equity (US) | — |
| TFX | TELEFLEX INC | 0.42% | Equity (US) | — |
| MNKD | MANNKIND CORP | 0.42% | Equity (US) | — |
| LIVN | LIVANOVA PLC | 0.37% | Equity (US) | — |
| — | CHARTWELL RETIREMENT RESIDEN | 0.36% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
Global X Aging Population ETF ·
NPORT-P period 2026-11-30
(filed 2026-04-29)
Net assets:
$89M
· 85 total positions
· equity 99.76%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | UCB SA COMMON STOCK | UCB SA | 4.17% | $3.7M |
| 2 | JOHNSON & JOHNSON COMMON STOCK | JOHNSON & JOHNSON | 3.72% | $3.3M |
| 3 | ASTRAZENECA PLC COMMON STOCK | ASTRAZENECA PLC | 3.60% | $3.2M |
| 4 | ROCHE HOLDING AG-BR COMMON STOCK | Roche Holding AG | 3.60% | $3.2M |
| 5 | MERCK & CO. INC. COMMON STOCK | MERCK & CO., INC. | 3.52% | $3.1M |
| 6 | WELLTOWER INC REIT | WELLTOWER INC. | 3.41% | $3.0M |
| 7 | CHUGAI PHARMACEUTICAL CO LTD COMMON STOCK | CHUGAI PHARMACEUTICAL CO., LTD. | 3.39% | $3.0M |
| 8 | ELI LILLY & CO COMMON STOCK | ELI LILLY AND COMPANY | 3.25% | $2.9M |
| 9 | REGENERON PHARMACEUTICALS COMMON STOCK | REGENERON PHARMACEUTICALS, INC. | 3.15% | $2.8M |
| 10 | AMGEN INC COMMON STOCK | AMGEN INC. | 3.11% | $2.8M |
| 11 | ABBVIE INC COMMON STOCK | ABBVIE INC. | 2.96% | $2.6M |
| 12 | EDWARDS LIFESCIENCES CORP COMMON STOCK | EDWARDS LIFESCIENCES CORPORATION | 2.89% | $2.6M |
| 13 | MEDTRONIC PLC COMMON STOCK | MEDTRONIC PUBLIC LIMITED COMPANY | 2.67% | $2.4M |
| 14 | BRISTOL-MYERS SQUIBB CO COMMON STOCK | BRISTOL-MYERS SQUIBB COMPANY | 2.63% | $2.3M |
| 15 | STRYKER CORP COMMON STOCK | STRYKER CORPORATION | 2.58% | $2.3M |
| 16 | SANDOZ GROUP AG COMMON STOCK | Sandoz Group AG | 2.56% | $2.3M |
| 17 | VENTAS INC REIT | VENTAS, INC. | 2.47% | $2.2M |
| 18 | CELLTRION INC COMMON STOCK | Celltrion, Inc. | 2.40% | $2.1M |
| 19 | ALCON INC COMMON STOCK | Alcon AG | 2.29% | $2.0M |
| 20 | BEONE MEDICINES LTD-ADR DEPOSITARY RECEIPT | BeOne Medicines AG | 2.05% | $1.8M |
| 21 | ASTELLAS PHARMA INC COMMON STOCK | Astellas Pharma Inc. | 1.98% | $1.8M |
| 22 | BOSTON SCIENTIFIC CORP COMMON STOCK | BOSTON SCIENTIFIC CORPORATION | 1.90% | $1.7M |
| 23 | DEXCOM INC COMMON STOCK | DEXCOM, INC. | 1.89% | $1.7M |
| 24 | HANSOH PHARMACEUTICAL GROUP COMMON STOCK | HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | 1.74% | $1.6M |
| 25 | UNITED THERAPEUTICS CORP COMMON STOCK | UNITED THERAPEUTICS CORPORATION | 1.48% | $1.3M |
Showing top 25 of 80 equity holdings.
Daily issuer data also available
(2026-06-09)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -0.11% | 5 |
| Feb | +0.77% | 5 |
| Mar | +0.08% | 5 |
| Apr | +0.11% | 6 |
| May | -0.35% | 6 |
| Jun | +0.29% | 6 |
| Jul | +1.70% | 5 |
| Aug | +0.34% | 5 |
| Sep | -3.46% | 5 |
| Oct | +0.89% | 5 |
| Nov | +1.23% | 5 |
| Dec | +0.54% | 5 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $35.03
SMA 50: $35.38
SMA 200: $35.46
Current: $34.57
EMA 12: $34.83
EMA 26: $35.04
MACD: -0.2117 | Signal: -0.0375
BEARISH
ADX (14): 11.59
RANGE
+DI: 35.84
−DI: 24.77
Momentum Oscillators
RSI (14): 43.41
NEUTRAL
Stoch %K: 40.27
Stoch %D: 31.41
Williams %R: -70.12
Volume & Volatility
BB Upper: $35.92
BB Lower: $34.14
NEUTRAL
OBV: -1,247
Vol SMA 20: 10,898
Vol ROC: 254.52%
ATR: $0.54
True Range: $1.44
HV 20: 15.5%
HV 30: 16.3%
HV 60: 16.8%
Data Summary
Data Points: 500
Last Updated: 2026-06-08T21:15:19.189000
Date Range: 2024-06-10T00:00:00 – 2026-06-08T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Options Activity
- IV Rank (30D)
- 83.16
- IV Rank (7D)
- 100
- Avg IV
- 49.1%
- Straddle (30D)
- $2.02
- Straddle (7D)
- $1.62
- P/C Volume
- 0.18
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 0.58
- Correlation (SPY)
- 50.9%
- R²
- 0.26
- Ann. Volatility
- 13.8%
- SPY Volatility
- 12.1%
Low volatility - stock moves less than market
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|